Good morning. My name is Chris and I will be your conference operator today. At this time, I would like to welcome everyone to The Chemours Company Q3 2018 earnings call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. Jonathan Lock, Vice President, Corporate Development and Investor Relations, you may begin your conference.

Good morning. Welcome to The Chemours Company’s third quarter 2018 earnings conference call. I’m joined today by Mark Vergnano, President and Chief Executive Officer, and Mark Newman, Senior Vice President and Chief Financial Officer. Before we start, I’d like to remind you that comments made on this call, as well as the supplemental information provided in our presentation and on our website, contain forward-looking statements that involve risks and uncertainties, including those described in the documents Chemours has filed with the SEC. These forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events that may not be realized. Actual results may differ and Chemours undertakes no duty to update any forward-looking statements as a result of future developments or new information. During the course of this call, management will refer to certain non-GAAP financial measures that we believe are useful to investors evaluating the company’s performance. A reconciliation of non-GAAP terms and adjustments are included in our release and at the end of this presentation. I will now turn the call over to Mark Vergnano, who will review the highlights from the quarter. Mark?

Thank you, Jonathan. And good morning, everyone, and thanks for joining us today. I'm excited to report our third quarter results, which reflect the hard work and diligence of our teams as we execute our strategy for long-term growth and value creation. Before jumping into the results, I wanted to highlight a number of recent achievements by the team that we are all very proud of. Last week, we released our first ever corporate responsibility commitment report, including our formal entry into the United Nations Global Compact as a participant. This report memorializes our commitment to making people's lives better through higher value chemistry, while being good stewards of the world we live in. In October, Chemours also achieved a great place to work certification, a recognition of the pride we have is a company and the spirit of our workforce. As a management team, we remain focused on our global talent pool and ensuring that we continue to attract the best and brightest to Chemours. I continue to be impressed with the team we have here at Chemours and I'm very proud of this achievement. So, now, on to the third quarter numbers. We grew adjusted EBITDA 14%, with each of our segments delivering year-over-year earnings growth, including a record quarter for Chemical Solutions. Strong margins in our Titanium Technologies and Fluoroproducts segment highlight solid execution, even when considering the expected seasonality in these two businesses as we move from the first half into the second half of the year. In the third quarter, we continued to execute on our commitment to return the majority of our free cash flow to our shareholders. Since announcing our new $750 million share repurchase plan on last quarter’s call, we have repurchased approximately 6.3 million shares through the end of October, including over 3 million shares in the third quarter alone. Looking ahead to the full year, we now believe that 2018 adjusted EBITDA will be in the bottom half of our original guidance range of $1.7 billion to $1.85 billion. This change is driven by the faster-than-expected decline in Ti-Pure TiO2 volume in the second half of 2018. We remain committed to our Ti-Pure value stabilization strategy and believe it is the right long-term strategic plan for our customers and for Chemours. In line with the change to adjusted EBITDA, we have also adjusted our free cash flow outlook for 2018 to approximately $650 million. However, as a result of share repurchases to date, we have revised our adjusted EPS range upward and, furthermore, believe we’ll be at the top end of this higher range. Looking further ahead, all of our businesses remain on the path to long-term growth and we remain focused on improved execution. We remain confident in our ability to meet or exceed our three-year financial targets as originally communicated at the end of last year. I will now turn the call over to Mark Newman to cover our third quarter financial results in more detail.

Thanks, Mark. I'll start my comments on slide four. We continue to see the results of disciplined execution of our strategy in our Q3 financial results. Most importantly, in the profitability of our businesses on both an earnings and margin basis. Net sales of $1.63 billion increased 3% or nearly $45 million from last year's third quarter, reflecting continued growth from our Fluoroproducts and Chemical Solutions segments, partially offset by lower TiO2 volumes, consistent with customer destocking in Titanium Technologies. GAAP net income increased 33% to $275 million, including a non-cash charge related to our Fayetteville facility. As we work toward a final resolution of our environmental matters at the Fayetteville site, we have taken a charge of approximately $30 million in relation to potential exposures in the third quarter. This charge is in addition to the cost of development and installation of state-of-the-art environmental control technology at the Fayetteville site and other remedial measures. On an adjusted basis, net income rose 33% when compared to last year's third quarter. This translated into a year-over-year increase in EPS and adjusted EPS of 40% and 41% respectively. Adjusted EBITDA improved 14% with an adjusted EBITDA margin expansion of 260 basis points to 26.7%. We generated approximately $226 million in free cash flow in the quarter, reflecting our earnings growth, lower seasonal working capital unwind than the prior-year, and higher capital expenditures as we complete our Corpus Christi Opteon plant. Our pretax ROIC of 42% this quarter demonstrates our commitment to invest in our portfolio through high-return projects even as we ramp up CapEx. Let's review our adjusted EBITDA performance on the next slide. Higher global average selling prices of Ti-Pure titanium dioxide along with increased price for our fluoropolymers products and favorable raw material pass-throughs in Chemical Solutions products delivered nearly…

Thanks, Mark. Turning to Fluoroproducts on the next slide, sales in the quarter were up 7% to $682 million, with volume up across the segment. Price improved modestly, which was offset by a small currency headwind. The headline story here continues to be our fourth generation low GWP refrigerant Opteon, where we see steady adoption in both mobile and stationary applications. Base refrigerant pricing has come off highs from earlier in the year, though, in total, we continue to experience solid demand for our portfolio of refrigerant products. On the polymer side of the business, we experienced volume growth despite supply constraints across several product lines, along with year-over-year price improvement. Fluoroproducts adjusted EBITDA was $182 million in the third quarter, up 15% from the same quarter a year ago. Margins expanded to 26.7% in the quarter, an approximate 200 basis point improvement from last year's third quarter. We continue to see the benefits of our pricing actions taken last year and into this year, offsetting modest refrigerant price declines and the impact of increased distribution and raw material costs. Let's review the Fluoroproducts performance drivers for Q3 in a bit more detail, starting with fluorochemicals. The conversion to low global warming potential refrigerants continues to drive demand for Opteon in mobile applications as well as Opteon blends for stationary applications. In the third quarter, we saw strong demand for Opteon result in overall volume growth, which more than offset modestly lower price on a year-over-year basis. Base refrigerant revenue continues to be flat on a year-over-year basis as currency and modest price erosion offset volume growth. As you know, base refrigerants in Europe have seen a lot of price volatility over the past year due to the large step down in the F-Gas quota that occurred this year. Following…

[Operator Instructions]. Your first question comes from Duffy Fischer of Barclays. Your line is open.

Yes. Good morning, fellows. First question is just around the margins in TiO2. With volumes down that much, with a lot of scuttlebutt about ore prices rising, even though you've got year-over-year pricing, you are able to increase your percent margin, can you kind of just talk about running at lower operating rates, what that's doing to your cost structure and what we should expect kind of in the next couple of quarters if we continue to run at lower operating rates?

Sure. Duffy, obviously, as you said, ore prices have gone up. We contemplated that in our plan. Our pricing to our customers has already contemplated that. So, that was already in the mix for us. As we see volume come down, and one of the reasons we’re so confident about our strategy, we have ways to adjust for that based on the way that our operating network works in terms of what facilities we can operate through and how we use our low-grade ore capability. So, from that standpoint, we’ve been able to adjust our plans in terms of what we produce to allow us to continue to have strong margins. That's the beauty of the Ti-Pure network, our manufacturing network and why we are very confident around our strategy of holding price and allowing volume to shift.

And I know it's difficult, but what visibility do you have kind of into the inventories, either customers, traders? Your volumes are down 10%. Venator’s volumes were down 17%. When you look at the vast majority of what TiO2 goes into, paint, plastics, clearly, that's growing at least several percentage points year-over-year. How quickly do you think we’re destocking and what's your best guess at when we get to some kind of endpoint?

Yeah. It’s a great question, Duffy. If you look at last year, last year, our volumes were up about 8%. Obviously, well above GDP. So, you know that, in some cases, we’re gaining some share, but in other cases people were putting in inventory. That happens, we know, when prices are going up. But when you look at it from the other side now as prices have stabilized, destocking occurs. One of the questions that I'm sure many of you are on your mind is did we not see this coming over the last quarter, and what I'd say is it's happening a little bit faster than we thought. We really, in our planning, thought that this phenomenon of destocking would really start taking hold really in the early part of 2019. What we’re seeing is it's happening in the second half of 2018. So, a little bit sooner than we expected, but that says that it should flush out sooner than expected as well. So, right now, we’re anticipating this will probably play out through the beginning of next year.

Great. Thank you, guys.

Yup.

Your next question comes from Laurence Alexander of Jefferies. Your line is open.

Hello. I guess two questions. One is, can you give a bit of a recess on how you think about the adoption of Opteon, given the current legal environment? And secondly, just to follow on Duffy's question, where do you see – are you seeing any indication from your customers about any change in underlying operating assumptions or are you confident that this is just a destock issue in the supply chain?

Yeah. For the first one, Laurence, we’re very confident around our patent base. I would call it, our patent fortress around Opteon. We have thousands of patents around this and we add to this patent estate every day, whether they are application patents, they are patents around process, they are patents that we call fingerprint patents. There so many aspects of this that we see a long-term – we've always said, we see a 10-year runway of growth for our Opteon product, one based on application as we go heavier into stationary, but, two, because we continue to believe that we can protect this very unique technology with the patents that we have in place. There is no one patent that hinges this whole Opteon phenomenon for us. There is multiple patents. Thousands of patents that really hinge that. So, we feel very confident around the patent side of this. To your second question around do we know this is destocking or something more, all of you know that TiO2 is a bellwether for the economy. So, we look at that very closely. We look at our market shares very closely. At this point in time, we believe this is a destocking phenomenon. We don't see anything beyond that at this point in time and that's how we’re operating business based on that.

Thank you.

Your next question comes from Robert Koort of Goldman Sachs. Your line is open.

Good morning, everyone. This is Chris Evans on for Bob. I realize you're a little early in your value stabilization approach and you mentioned a bit earlier that the destock came a little bit earlier than you expected. But, I guess, just for customers that you have contracted under value stabilization and as you launch that program, did you get enhanced visibility into this destock? And do you think if you were fully launched in this program, you would have been better able to adjust production ahead of time to compensate for the volume softening?

Perhaps, Chris. I don't know if we’re getting any better view from that because it's not just the destocking at a customer. Remember, it’s destocking through the whole chain, right? So, this is destocking at distributors, at our direct customers and downstream from them. So, I'm not sure everybody has visibility from that standpoint. So, I'm not sure that would be any different. I will tell you, though, we are absolutely committed to the strategy. We think it's the right one. As I've said many times before, we’ve worked really hard over the last 18 to 24 months to get our price point where it is today. We think this price point allows us to have the proper margins, allows our customers to have the right margins for themselves and, at the same time, it gives us reinvestment economic, so that, in time, we can add capacity for their growth. So, we think this is the right strategy for us, for our customers. And again, it's no accident where we ended up in terms of the price point we’re at.

Great. And you reiterated the 2020 targets with your earnings report. And, notably, this this includes a 500 bps improvement in your margins. Can you describe some of the moving pieces here that gets you that outcome? And just curious if you think you can achieve this without TiO2 margins improving over this period?

Yeah. Well, we absolutely are committed to all aspects of that plan. The reason we laid out a three-year plan is because you can't really peg it to a quarter or to a year, but over that period of time, we’re very confident around it. I would say look at this quarter's performance. We've expanded margin in Fluoro, in Chem Sol, and in TiO2. So, I think we’re executing off of this extremely well. What we talked about a year ago was we wanted to fix and expand our Chemical Solutions business. We’re doing that. On the Fluoro side, Opteon continues to be a good growth mechanism for us, both in mobile, but also as stationary grows. We’re expanding the business in our fluoropolymer side with application development. That's playing out. You're seeing the margin expand there. And, obviously, on the TiO2 side, value stabilization continues to be what we're driving for, to stabilize price over time, which is something that we believe is important for us, our customers and also our investors. And at the same time, we’re going to deliver the bulk of our cash back to our shareholders. So, I think you need to look at this quarter as a bellwether of what we’re doing on our strategy because that's why we believe the three-year goals are the right ones.

Great. Thanks, Mark.

Your next question comes from Matthew DeYoe of Vertical Research. Your line is open.

Good morning. As it relates the 4Q guidance in Titanium Technologies, what do you believe the right decremental margins are for the business here? It seems like the new volume guidance implies maybe another 10% drop, but if you’re talking about the low end of your new EBITDA range, you could go 100% decrement and still maybe not get there? so, a little bit more clarity would be great.

Okay. Sure, Matt. So, first of all, our guidance is a range, right? You need to look at the range from that standpoint versus just going to the low end of that. So, we have a range on purpose based on that. Number two, price will hold. You will not see any change in our local price. That will stay stable. So, your only variable there will be volume, and that volume will really be based on how we operate our facilities. And as I've mentioned to Duffy upfront, we have the ability to be able to move our production the right way within our facilities. So, I can’t give you an indication of what that's going to mean for margin. What I can tell you is there will be no drop in margin attributed to price. It'll be just the utilization of our assets.

And if I could just add to what Mark said – this is Mark Newman – I think what we have said previously is that we would expect that our TiO2 margins over time could be in the low 30s. Obviously, in the quarter, it was very close to 34%. Sequentially, very similar to 2Q of this year. Obviously, with lower volumes, to Mark’s point, you would expect some higher fixed cost per unit. So, you would see a little bit of margin compression. But I think we are very comfortable with our guide to be in the low 30s.

Okay. And then, as it relates to Opteon prior guidance, I think it was about 20% growth. Is that still in play on the year? And then, what are you expecting next year, just noting perhaps some of the F-Gas tailwind isn't quite the same year-over-year?

Yeah. So, we’ll give guidance later on, next year. Obviously, not today. From a standpoint of Opteon growth, we continue to see mid-20s type growth. So, we continue to see the solid growth on Opteon.

Thank you.

Y2our next question comes from Josh Spector of UBS. Your line is open.

Yeah. Hey, guys. Just had a question on the ore flexibility and how much room you have less to use that as a lever going forward. So, I guess, if I think year-over-year and, say, volumes flat ex destocking, do you have room to bring in more low-priced ore? Or is that going to cause you guys to de-raise some capacity?

Yeah. We look at this – think of it as a giant linear programming issue for us. We do have a little bit of room, but I would just caution everyone, you can't turn on a dime, right? You've got to get the ores in place. You have to have your production plans in place. So, we anticipate constantly around what our customers need, what grades they're going to need, what facilities need to be producing those. And as we are in a place right now where we see volumes coming off, at least for the next quarter, we task our facilities in the right manner. So, you're always going to utilize your low-grade ore facilities as best you can and with the right mix for the products that you need. So, that’s all contemplated inside of our planning, which is why we feel confident again when we see a perturbation in volume around how we operate because we can operate more at these lower cost, low-grade ore facilities when that happens.

Okay, thanks. And just a follow-up from a prior question. So, in term of pricing sequentially, how confident are you on flat pricing into fourth quarter? I guess, is that based on contracts that you already have in place? I guess, I'm a little bit surprised, given the destocking, that pricing will be flat?

Yeah. I'm completely confident. We are not going to waver on local price.

Very clear. Thank you.

Your next question comes from P.J. Juvekar of Citi. Your line is open.

Good morning, Mark. You mentioned your mid-20% growth in Fluoroproducts. But there has been some slowdown in your Fluoroproducts growth in the last 18 months. So, can you talk about that? And do you think the recent Supreme Court decision not to hear the EPA case, could that have some impact on Fluoro business?

Yeah. Make sure I understood the first part, P.J., you're talking about Opteon growth?

Yeah. Opteon growth.

Yeah. So, I would say the only adjustment we’ve seen in Opteon growth has been a little bit slower auto build rate in Europe. Remember, we’re 100% penetrated in Europe for the auto side. And so, auto builds have been a little bit slower in Europe, as most of you know, over the second half. Little bit of currency effect there as well. Currency has sort of shifted. That’s the only change we’ve seen on that side. On the US side, we’re only about 50% penetrated. We continue to believe, despite the Supreme Court ruling, that we will be 100% penetrated by 2021. And that's really driven off of the CAFE standards and the move that the auto manufacturers are making toward that. So, I don't think – we are disappointed that the Supreme Court didn't want to hear the appeal on SNAP. But it really isn't going to affect what we see over the next few years in terms of our growth rates going forward.

And just one question on TiO2 side, can you talk about ore stocking that you mentioned? How much can you do there? Just kind of give us some idea of what you can do on buying ores ahead of price increases?

Yeah. One of things, we've used a little bit of cash and we’re using a little bit of cash for the rest of the year. For that very reason, we've taken up a little bit more ore than we normally would. We think it's a good prudent decision from a cost perspective as we sort of look out the next 12 to 18 months. That is a little bit more use of cash than we have planned, but we think it's a prudent decision for where we are right now. We’re not going to overboard with that, but we do think it's the right thing to do for the business and for our earnings going forward.

Thank you.

Your next question comes from Arun Viswanathan of RBC. Your line is open.

Great, thanks. Good morning. I'm just wondering if you could give us an idea of what you're seeing from an inventory standpoint across your customer base in the different regions? And how do you get confidence as far as where you are in that cycle? Maybe you can just give us some markers on what you’re seeing and what normal would be? Thank you.

As you look at this destocking phenomenon, what we're seeing right now is no single segment – it’s occurring across segments, it’s occurring across the world. So, I can’t tell you it’s targeted any one place because it's really not. Again, as I mentioned from earlier, a little bit earlier than we thought in our planning. We thought this would start maybe at the end of this year, but really be more of a 2019 phenomenon and we’re seeing it really play out heavier in the fourth quarter of this year than we had originally planned. So, I think that's going to play through. We’re going to keep very close to this and understand if there's any shift in terms of market share if there's anything else going on. But at this point in time, I would say, across the board, happening a little bit faster than we anticipated with no one region being stronger than another.

But are you able to provide any metrics on days of supply or anything like that? Especially for China, wondering if you have any look into the intermediaries and their position there as well, the distributors?

It's really hard for us to do that, Arun, primarily because this – as I said, it’s not just with your customer. It’s all the way down the chain and we just don't have that visibility to see that. But, again, if you just look at the past, right, I think it helps you really understand this. 8% up last year, well over GDP. There's going to be – you know there was some build occurring in there. And as we have always said, this industry operates at about a GDP growth rate. It’s a perfect indicator, I think, of GDP. So, you're going to have a period of time when prices stabilize where you're going to come below that line for a bit until you get back on it. So, I think this is playing out again in a very traditional way. It just happened a little bit sooner.

And just a quick follow-up, if I may, on TiO2, given the inflation that you have seen, what’s your outlook for the ability to pass that on, I guess, in this type of environment? Would we expect kind of that as a greater possibility when restocking happens next spring or how should we think about the inflation impact as well? Thank you.

Well, our price points with our customers as we move them into value stabilization contracts contemplates the ingredient costs that we have. So, these are all taken into account in terms of how we’re putting these contracts together. So, I feel that we have that well covered at least from what we see from our raw materials going in.

Thank you.

Your next question comes from Vincent Andrews of Morgan Stanley. Your line is open.

Thank you. And good morning, everyone. You mentioned that there was some negative customer mix in TiO2 during the quarter, if you could just give us a little more insight into that. And then, as it relates to the fourth quarter, is there any risk of negative mix? I get it that you're not going to take prices down, but could mix be negative in the fourth quarter?

Yeah. I would say the mix issue – the reason we said it was customer mix, one, because it is, is it's not really related to any industry or it’s not related to any region. It really was just the mix of customers that we have. So, you can imagine that larger customers are going to have different price points than others. So, think of it from that standpoint. So, I wouldn't read anything into that. And I would say, I don't anticipate anything being that different going forward. What we continue to do with our key customers is develop new applications with them. That's where we get most of our pricing improvement, is when we bring out new products and new applications and that's something that we continue to do to try to offset any mix that we see. But I would say the mix is purely around the buying patterns of our customers. And I think that's going to settle itself out as we finished the destocking period.

Okay. And just as a follow-up on share repurchases, obviously, you've got your long-term plan, but what is the appetite to sort of accelerate the pace of share repurchases, just given where the stock price is?

Well, what we've said when we brought the $750 million onboard is that we would do this ratably. As Mark has mentioned, the $250 million will occur this year – basically has occurred this year. We’ve looked, at this point in time, to be ratable over the next two years. So, you should plan on at least $250 million next year and $250 million the year after. However, we’re always in constant conversation with our board. And if we feel that there needs to be adjustment to that, we’ll have that conversation with the board around that.

Very clear. Thank you very much.

Your next question comes from James Sheehan of SunTrust. Your line is open.

Thank you. Good morning. Very strong results in Chemical Solutions. Can you give us a little bit more color about what's driving that and whether you think that strength is sustainable in 2019?

Jim, I'm so excited we got a question about Chemical Solutions. The team has done a great job there. I would say, one is they continue to drive cost within that business segment to make sure we’re efficient. But they've been very good at looking at price as well. So, price, as you see, has been a positive in the quarter around that, whether that's in our mining solutions business which is becoming tighter in that market or even in our other businesses, whether it’s glycolic acid or methylamines, we see some opportunities there as well. So, the team has done a really good job of segmenting their business, getting price up for the value of our products, at the same time, holding costs down. As I've always said, this quarter, they were in the 15% range on EBITDA margin. We have always said that in time we believe this segment will approach the margin of the total Chemours Company and they're making that progress.

Right. And back on the Supreme Court question, how much faster would you think adoption rates have been in the US if you had prevailed in that legal case?

Yeah. I think that – again, I don't think it would've been much different on the auto side. As I said, we’re on a path that will be fully penetrated with HFO in the US auto market by 2021. It could've helped a little bit of acceleration perhaps on the stationary side, but what's happening is you're seeing this now shift from what was going to be a federal mandate to being a state mandate. So, there's already 16 states that are adopting this same kind of SNAP regulation to drive these kind of products into the marketplace. So, what was, at one time, in our opinion, a little bit more efficient to be done at the federal level is really happening at the state level as well. So, we think that this will add to the acceleration of Opteon into the marketplace as well.

Thank you.

Your next question comes from Jeff Zekauskas of J.P. Morgan. Your line is open.

Thanks very much. Mark, your volumes in TiO2 will probably be down 10% or 15% in the fourth quarter. Are your volumes in the United States down at that rate? That is, is it not only in Asian destocking or European destocking, but the volume growth – the volume deceleration is actually comparable in the different geographies or is Europe and Asia twice what the United States is or three times? How do you see that?

To be honest, Jeff, they're across the board almost the same. So, we’re not seeing any one region being higher than anyone else. I'd say, they are very, very equal across, including China, including Asia. So, we’re not seeing it in any one region, again, which is why we believe this is a true destocking phenomenon, not a market share issue, as we look at this. So, we don't see perturbations in this through any region.

Okay. And then, secondly, many of the titanium dioxide companies in the West have talked about all kinds of environmental issues in China. And the export data out of China isn't as good as it used to be, but it looks like – or it may be the case that China exported an incremental, I don't know, 200,000 tons of TiO2 outside of China this year, which is about equivalent to incremental demands in TiO2. Do you think that's true? And do you think that those were tons that were not sold inside of the domestic Chinese market, so that there was really no overall change in Chinese titanium dioxide production? Or do you think that Chinese titanium dioxide production really stepped up? So, how do you assess that? And do you think it affected prices this year?

Yeah. So, I’ll tell you at least our theory, right? Because, as you know, China is a bit opaque, right? We are convinced that this environmental work that was done within the country was real, that capacity was taken out or shut down. Some for a period of time; some from a permanent standpoint. We also believe that the economy has slowed down in China, so there is a logic that product that was staying domestically maybe came out at the same time. So, I don't think that – I think it's – the theory, the case for us is, yes, it had come out because it didn't have a place in China. So, it was looking for markets outside. Again, our theory constantly has been, we don't believe TiO2 is a fungible product, and so we've never seen it intercept our business because we think it’s a different grade than where we sell our products and to the customers we have. But I’d say, net-net, there's no new capacity coming on stream. This isn't adding to the capacity side. It's just exports, maybe perhaps had been bit higher because they didn't have a home inside of China, but they're not intercepting the higher grade TiO2.

Okay, great. Thank you so much.

Your next question comes from Don Carson of Susquehanna. Your line is open.

Mark, I had a question on value stabilization. And, I guess, what's the willingness of customers to enter into these types of contracts when the price is falling? I can certainly understand why they might want to lock it in when the price is rising. And so, if you could comment on that. And, currently, what percentage of your volumes are under value stabilization contracts and where do you see that evolving over 2019?

Yeah. Don, I would say the value proposition for our customers is really long-term partnership, long-term supply. The customers who are really gravitating to this new idea are understanding that, for them to grow, they need a consistent and constant supply of TiO2. They need a supplier that is willing to invest over the long-term in adding that capacity. And so, they understand where we are at a price point is good for us. One, it’s solid margins for us today. We’re not looking to expand from that place; we’re looking to have good reinvestment economics; and good for them in terms of where they are right now. That's basically the conversation we have with customers. So, those that really are gravitating to this get that, and they understand that this is a way for them to be able to secure long-term partnership, long-term ability to have TiO2 available to them. Always conversations about the starting point on price. And as I said earlier in the call, we thought very hard this was a calculated time for us to implement value stabilization because, we think the price point, we've done a lot of work to get it to this place and we think it's the right place to start, and that's why we are holding firm around the starting point from a price point.

And what's the percentage of your volume currently under these contracts? Can you comment on how big it’s going to be as a percentage of your overall book?

Yeah. We haven't shared where we are right now, but I'll tell you this will be the majority of our business. We’ll be under these contracts. That's what we’re tracking to. So, I feel confident that's where we’ll be. But we will have the majority of our business under these contracts. Without going into a lot of detail here, what we've also talked about is there would be another mechanism for people to buy, which would be something we call Ti-Pure Flex, which is a way for them to come in and buy on a semi spot basis with no commitments from us and no guarantee that that product will be available. But you should think of the bulk of our volume will be going out through these contracts.

Thank you.

Your next question comes from Roger Spitz of Bank of America. Your line is open.

Thank you very much. Good morning. Do you expect that in TiO2 you might lose market share over the near term if customers decide to take more towards the contractual minimums? And can you tell us what percent of your TiO2 volumes can be down if your contractual book took their contractual minimums?

Yeah. I can't really talk through that second piece. But I will say that, part of our strategy here is to really hold price and allow volume to fluctuate with our customers’ needs from that standpoint. Our goal is not to lose market share through this plan. We think that this again is valuable to our customer base going forward. So, from that standpoint, I would say I don't anticipate market share loss, but I, at the same time, will tell you we are dedicated to the strategy of value stabilization and we’re going to move forward with it.

Okay. I think in the past call and previously, you had mentioned that your unique volume position of your particular type of ore provide you a better ability to negotiate and slow the ore price increases. Can you tell us – if I heard that correctly, can you tell us how that worked during the last two times slag prices rose?

Yeah. Again, we are the market for chloride ilmenite because we’re the big user for that. We are one of many who buy slag and rutile from that standpoint. The value proposition we have that’s maybe different from other folks is we could buy from a mine who has both, right? So, we are able to take the ilmenite along with either slag or rutile and be able to package that in a different way. That’s really our competitive advantage other than size. That's our competitive advantage with the ore producers. Again, we worked hand in hand with our ore producers from that standpoint, try to find a win-win opportunity as we’re doing those buys. But we have that unique opportunity to be able to buy both, which in many times is very helpful to those suppliers.

Thank you very much.

Sure.

Your final question comes from Bob Koort of Goldman Sachs. Your line is open.

Hey, thanks. Just wanted to follow-up. Can you comment on your decision that you made earlier this quarter to expand your internal ore production? Just curious how much and what grades you source today from your mine in Florida? Where is that heading? And then, just longer-term, do you see any benefit to increasing your vertical integration and reducing your market exposure to volatile ore prices, especially given this value stabilization approach?

Yeah. Chris, we did make a decision to expand in the area where we already are, which is the southeast of the US. We have some mine opportunities there that are really – it’s a great body of ore. It’s perfect for us because it’s ilmenite. It really is sort of a sweet spot in terms of the percentage of the ore for the way we operate our manufacturing facilities. So, from that standpoint, it was sort of a no-brainer for us to be able to do that. Further downstream doesn't make sense for us we don't really think that's the best use of our capital where we have other areas to use our capital to grow. It’s something we will always keep our eye one, but, I would say, at this point in time, it doesn't really make sense based on the buying power we have in the market and the ability for us to be able to buy ores. So, I don't want you to be confused by why we did that with this orebody. It’s just this made a lot of sense. The return on this was tremendous because we’re already physically there and it's just – think of it as an extension of the mine we already have versus going in somewhere else where we didn't have any presence.

That’s great. And just maybe just a last quick one on pricing. I appreciate your commentary. And maybe for stronger pricing which seems to be better able to be put through in the US marketplace. But I'm just curious how you think the other regions may trend, particularly as your inventories and peers’ seem to be percolating through year’s end and the competitive dynamic is maybe a little bit more robust than you see in the US?

I missed the question, Chris.

Just curious if you – you commented that you are – your price stabilization – your value stabilization is going to give you flat to positive pricing going forward? In the US marketplace, I can somewhat get behind that. Just curious in the other regions as inventories are rising and your competitors are pushing more product, as Jeff pointed out, from China. Just curious how you think pricing will hold in the rest the world where maybe there’s not as a disciplined marketplace.

We’re going to be disciplined here. We’ve been very, very clear on our strategy. We’ve been clear with our customers on our something. We will not vary by region. We’ll not vary by segment. We believe this is the right thing to do. We believe this is the right thing to do for our customers as well as for Chemours. So, you're not going to see that – the local price vary anywhere in the world.

Okay, thank you.

That concludes our question-and-answer session. I will now turn the call back to Mark Vergnano for closing comments.

Thanks, Chris. And listen, I just want to thank you all for the time this morning. Always thank you for your continued interest in Chemours. As I said throughout the call, but also in the remarks we started with, we are committed to our three-year plan that we laid out to you last year. We are executing off of that strategy and I would say this quarter should give you confidence that we are executing exactly what we told you that we’re dedicated to value stabilization in our Titanium Technologies business, that Opteon continues to be a strong growth engine for us that we will continue to optimize and drive, our fluoropolymers business continues to be extremely strong as we drive application development and move the margin up in that business, and, as you've seen, our Chemical Solutions business is approaching the margins of the rest of the company as per our plan. And we’re going to do that all at the same time we’re delivering the bulk of our cash back to our shareholders. So, hopefully, this gives you confidence on the strategy that we’re driving and the three-year goals that we’re driving towards. So, again, thank you all for the time and your interest in Chemours.

This concludes today’s conference call. You may now disconnect.